MA43352A - Protéine sans phénylalanine pour le traitement de la phénylcétonurie - Google Patents

Protéine sans phénylalanine pour le traitement de la phénylcétonurie

Info

Publication number
MA43352A
MA43352A MA043352A MA43352A MA43352A MA 43352 A MA43352 A MA 43352A MA 043352 A MA043352 A MA 043352A MA 43352 A MA43352 A MA 43352A MA 43352 A MA43352 A MA 43352A
Authority
MA
Morocco
Prior art keywords
protein
phenylalanine
food
phenylketonuris
treatment
Prior art date
Application number
MA043352A
Other languages
English (en)
Other versions
MA43352B1 (fr
Inventor
Bernhard Hoffmann
Natalia Jablonka
Yvonne Mücke
Stefan Rasche
Stefan Schillberg
Original Assignee
Metax Inst Fuer Diaetetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Inst Fuer Diaetetik Gmbh filed Critical Metax Inst Fuer Diaetetik Gmbh
Publication of MA43352A publication Critical patent/MA43352A/fr
Publication of MA43352B1 publication Critical patent/MA43352B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La présente invention concerne une protéine alimentaire recombinante exempte de phénylalanine et une protéine alimentaire à haute valeur biologique. L'invention concerne en outre un vecteur codant ladite protéine alimentaire, des microorganismes exprimant ladite protéine, un procédé de production de ladite protéine et une composition diététique comprenant ladite protéine destinée à être utilisée comme médicament et / ou aliment à des fins médicales spéciales. Chez les patients présentant des accumulations de phénylalanine dans le corps.
MA43352A 2016-09-01 2016-09-01 Protéine sans phénylalanine pour le traitement de la phénylcétonurie MA43352B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (fr) 2016-09-01 2016-09-01 Protéine sans phénylalanine pour le traitement de la phénylcétonurie

Publications (2)

Publication Number Publication Date
MA43352A true MA43352A (fr) 2018-03-07
MA43352B1 MA43352B1 (fr) 2019-08-30

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43352A MA43352B1 (fr) 2016-09-01 2016-09-01 Protéine sans phénylalanine pour le traitement de la phénylcétonurie

Country Status (27)

Country Link
US (1) US10640538B2 (fr)
EP (1) EP3290436B1 (fr)
JP (1) JP6954676B2 (fr)
CN (1) CN109661401B (fr)
AU (1) AU2017317652B2 (fr)
BR (1) BR112019004270A2 (fr)
CA (1) CA3033271C (fr)
CY (1) CY1121886T1 (fr)
DK (1) DK3290436T3 (fr)
ES (1) ES2742175T3 (fr)
HR (1) HRP20191406T1 (fr)
HU (1) HUE044665T2 (fr)
IL (1) IL265015B1 (fr)
LT (1) LT3290436T (fr)
MA (1) MA43352B1 (fr)
MD (1) MD3290436T2 (fr)
ME (1) ME03510B (fr)
MX (1) MX2019002422A (fr)
NZ (1) NZ750498A (fr)
PL (1) PL3290436T3 (fr)
PT (1) PT3290436T (fr)
RU (1) RU2764796C2 (fr)
SA (1) SA519401175B1 (fr)
SI (1) SI3290436T1 (fr)
UA (1) UA124630C2 (fr)
WO (1) WO2018041920A1 (fr)
ZA (1) ZA201901505B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用
CN110746494B (zh) * 2019-09-27 2021-07-20 深圳市诺维健生物技术有限责任公司 一组特殊膳食蛋白质

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
AU4413096A (en) 1994-12-02 1996-06-19 Indiana University Foundation Phenylalanine free proteins
EP1092769B1 (fr) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Des "tags" polypeptidiques pour la détection et la purification de polypeptides
ES2301579T3 (es) * 2000-12-07 2008-07-01 Dsm Ip Assets B.V. Prolil endoproteasa a partir de aspergillus niger.
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
CN101688213A (zh) 2007-04-27 2010-03-31 陶氏环球技术公司 用于快速筛选微生物宿主以鉴定某些在表达异源蛋白质方面具有改善的产量和/或质量的菌株的方法
WO2010124180A1 (fr) * 2009-04-23 2010-10-28 Phasebio Pharmaceuticals, Inc. Protéine de fusion de phénylalanine hydroxylase et procédés pour traiter une phénylcétonurie
WO2013133691A1 (fr) * 2012-03-09 2013-09-12 N.V. Nutricia Composition nutritionnelle liquide comprenant des acides aminés libres
US20150126441A1 (en) 2012-03-26 2015-05-07 Pronutria, Inc. Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods
US20150307562A1 (en) 2012-11-20 2015-10-29 Pronutria Biosciences, Inc. Engineered secreted proteins and methods
WO2016046234A2 (fr) 2014-09-22 2016-03-31 Nexttobe Ab Protéines recombinées sans phe destinées à être utilisées dans le traitement de la phénylcétonurie

Also Published As

Publication number Publication date
RU2019109142A (ru) 2020-10-01
NZ750498A (en) 2023-01-27
PL3290436T3 (pl) 2020-01-31
CY1121886T1 (el) 2020-10-14
EP3290436A1 (fr) 2018-03-07
LT3290436T (lt) 2019-10-10
ME03510B (fr) 2020-04-20
CN109661401B (zh) 2023-12-19
RU2764796C2 (ru) 2022-01-21
CA3033271A1 (fr) 2018-03-08
IL265015A (fr) 2019-04-30
MX2019002422A (es) 2019-07-04
MD3290436T2 (ro) 2019-10-31
CA3033271C (fr) 2024-04-02
RU2019109142A3 (fr) 2021-01-27
DK3290436T3 (da) 2019-08-19
EP3290436B1 (fr) 2019-06-05
ES2742175T3 (es) 2020-02-13
BR112019004270A2 (pt) 2019-06-04
CN109661401A (zh) 2019-04-19
UA124630C2 (uk) 2021-10-20
HRP20191406T1 (hr) 2019-11-15
PT3290436T (pt) 2019-08-30
AU2017317652A1 (en) 2019-02-28
US20190202872A1 (en) 2019-07-04
JP6954676B2 (ja) 2021-10-27
JP2019533988A (ja) 2019-11-28
SA519401175B1 (ar) 2022-01-08
ZA201901505B (en) 2020-08-26
MA43352B1 (fr) 2019-08-30
AU2017317652B2 (en) 2020-11-19
WO2018041920A1 (fr) 2018-03-08
SI3290436T1 (sl) 2019-11-29
IL265015B1 (en) 2024-04-01
US10640538B2 (en) 2020-05-05
HUE044665T2 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
MA47313B1 (fr) Formulations sous-cutanées d'anticorps her2
MY173699A (en) Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins
PH12017501473A1 (en) Novel proteins specific for pyoverdine and pyochelin
WO2012081982A3 (fr) Composition à base de protéines de lactosérum présentant une astringence réduite
MA41067B1 (fr) Composition comportant de la chitine et des protéines digestibles
WO2017062468A8 (fr) Agonistes de ppar, composés, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci
EA201891608A1 (ru) Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана
MA43352A (fr) Protéine sans phénylalanine pour le traitement de la phénylcétonurie
MA45172B1 (fr) Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées
WO2020109620A3 (fr) Souches bactériennes pour utilisations médicales
EA201891610A1 (ru) Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
MA43474B1 (fr) Systèmes de formulation pour glycolipides antimicrobiens
EA201792144A1 (ru) Стабильный препарат для парентерального введения тапентадола
Pang et al. Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link
BR112012008843A2 (pt) Composto, composição farmacêutica, uso do composto, e. mistura
MX2020004192A (es) Composiciones nutricionales densas en proteinas para su uso en el tratamiento y/o la prevencion de una afeccion relacionada con la perdida de masa y/o fuerza muscular.
MX2019014697A (es) Proteínas del receptor para productos finales de la glicación avanzada (rage) para el tratamiento de fibrosis y enfermedades mediadas por daño al adn.
BR112018008769A2 (pt) formulações farmacêuticas, formulações líquidas aquosa reconstituída e liofilizada, seringa, método de fabricação de uma formulação farmacêutica, método para tratamento de uma doença e uso de uma formulação reconstruída
MX2022001489A (es) Proceso para la preparacion de una composicion que comprende un polipeptido de proteina d.
MX2021015501A (es) Anticuerpos y metodos de uso.
MX2021008507A (es) Moleculas que se unen al receptor leucocitario similar a inmunoglobulina subfamilia b miembro 3 (lilrb3) y usos para las mismas.
Jang et al. Superficial mycosis of the foot caused by Cladophialophora boppii
EP4279080A3 (fr) Traitement et prophylaxie d'une infection k. pneumoniae
MX2022007509A (es) Formulacion estable y de alta concentracion del anticuerpo nimotuzumab.
Eduardovna The state of periodontal tissues in 12-year-old children from Illichivs’k (Ukraine)